GRI Bio

GRINasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$4.700 M

$2.15 +4.88%

Close of 23 Sept 2026

Revenue

—

Not reported

Earnings

-$12.0M

Loss-making

Shares outstanding

2,186,115

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 500 →

#463Processa PharmaceuticalsPCSA$5.28M
#464Cadrenal TherapeuticsCVKD$4.71M
#465GRI BioGRI$4.70M
#466Jaguar HealthJAGX$4.63M
#467Can-Fite BioPharmaCANF$4.63M

What if GRI Bio were worth as much as…

Open the what-if tool →

Gold $29.8T

$13,652,954

Per share 6,350,211× higher

Bitcoin $1.69T

$774,945.72

Per share 360,440× higher

Nvidia $5.43T

$2,486,050

Per share 1,156,302× higher

Or at a round number

$10.0M $20.0M $50.0M $100.0M

Where these numbers come from

Share counts and financials for GRI Bio are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 24 Sept 2026. Read the methodology.